RNA Therapeutics in Cardiovascular Disease

Area of Science:

• Molecular Biology
• Genetics
• Cardiovascular Medicine

Background:

• Noncoding RNAs (ncRNAs) play crucial roles in physiological and pathophysiological processes.
• Modulating ncRNAs is a potential therapeutic strategy.
• ncRNAs include microRNAs (miRNAs) and long noncoding RNAs (lncRNAs) with distinct regulatory functions.

Purpose of the Study:

• To review the role of specific miRNAs and lncRNAs in cardiovascular diseases.
• To explore the therapeutic potential of targeting ncRNAs for conditions such as heart failure, myocardial infarction, fibrosis, and atherosclerosis.
• To discuss current tools for modulating ncRNA expression and challenges in clinical translation.

Main Methods:

• Literature review and synthesis of existing research on ncRNAs in cardiovascular pathology.
• Identification and summary of specific miRNA and lncRNA examples relevant to cardiovascular diseases.
• Analysis of therapeutic strategies and challenges for ncRNA-based treatments.

Main Results:

• Identified specific miRNAs and lncRNAs implicated in the pathogenesis of cardiovascular diseases.
• Highlighted the potential of these ncRNAs as novel therapeutic targets.
• Discussed available methods for inhibiting or overexpressing ncRNAs.

Conclusions:

• Noncoding RNAs represent promising therapeutic targets for a range of cardiovascular diseases.
• Further development of RNA-based therapeutics is needed to improve efficacy, specificity, and delivery.
• Addressing challenges in RNA therapeutics translation is crucial for clinical application.